Description
Cedars-Sinai Medical Center is seeking applicants for an inaugural BRCA Center Director. The Director of the BRCA Center (Center) will provide overall executive direction and strategic leadership for all clinical, operational, academic, fundraising, and business development activities involving the Center consistent with the high aspirations of the program. The Director will lead these activities in partnership with academic, hospital and health system leadership including relevant Department Chairs, Institute Directors, and scientific faculty and medical staff. Collaboration and partnership skills are essential for the Director to shape an environment for creative, entrepreneurial scientific investigation and clinical implementation.
Key Responsibilities
Develop and oversee a robust clinical program for the assessment and care of patients and families with BRCA mutations.
In cooperation with leadership, draft and deploy a strategic plan for the center required to support the successful development of a nationally recognized and extramurally funded research and clinical program of excellence for BRCA cancers, including talent, space, and financial requirements.
Create an integrated, collaborative “team science” culture that will enhance all clinical and research activities.
Develop a robust mechanism for the exchange of scientific knowledge to the national and international scientific communities such as databases and web sites that can accelerate research globally on BRCA relevant cancers.
Actively participate in philanthropic efforts to support and grow the Center.
Qualifications
Research & Programmatic
- Multidisciplinary patient care collaboration: Demonstrated commitment to building and sustaining multidisciplinary collaboration to improve BRCA patient care and experiences across the care continuum.
- Scientific leadership in BRCA research: Nationally and/or internationally recognized scientific leader with demonstrated expertise and a strong publication/innovation record in a BRCA-related research area.
- Program development expertise: Demonstrated experience designing, launching, expanding, and scaling BRCA-related programs (clinical, research, education, and/or operational initiatives).
Leadership
- Visionary, collaborative executive leadership: Experience providing collaborative and visionary leadership that sets clear strategic direction for the BRCA Center.
- Proven administrative and organizational leadership: Track record of administrative accomplishment, including leading interdisciplinary teams and oversight of departments, centers, and/or institutes; able to translate strategy into measurable outcomes.
- Collegial, participative leadership style: Effective team leader who works constructively within collaborative settings; demonstrates a participative management style that promotes engagement and shared ownership.
- Talent leadership (recruitment, retention, development): Demonstrated ability to attract, retain, and lead diverse, high-performing teams of clinicians, scientists, leaders, and staff; strong workforce development capability.
- Stakeholder leadership beyond formal authority: Ability to inspire, mobilize, and align key stakeholders across the organization and external partners outside direct reporting lines.
Communication
- Influential, ethical decision-making and communication: Presents ideas clearly and effectively, while demonstrating emotional maturity, sensitivity, and respect for colleagues’ perspectives and organizational values; earns credibility through balanced judgment.
- Exceptional people and relationship skills: Demonstrated interpersonal effectiveness characterized by empathy, warmth, fairness, motivation, positivity, and active listening; recognized for earning and maintaining respect.
Values
- Accountability and ownership: Demonstrates personal accountability by assuming ownership for outcomes, managing risk, and ensuring performance across areas of responsibility.
- Integrity and candid advisory judgment: Trusted partner who provides direct, candid (“unvarnished”) guidance and recommendations in the best interest of the organization; consistently demonstrates the highest ethical standards and integrity.
MINIMUM REQUIREMENTS:
MD, MD/PhD, or equivalent
Board Certification in area of expertise
Ability to obtain and maintain CSMC Medical Staff Membership
Ability to obtain and maintain an unrestricted California medical license
Eligible for recommendation to an Associate Professor or Professor rank in the Medical Center’s professoriate series
Demonstrated national scientific leadership in a BRCA research field
A proven track record of peer reviewed extramural funding in a BRCA research field
Current federal research funding in a BRCA research field
NOMINATIONS AND APPLICATIONS: Interested candidates should provide a curriculum vitae and a letter of interest that describes their interest in the role including, but not limited to, relevant educational, teaching, and leadership background. All interactions will remain confidential, and no inquiries will be made without the consent of the applicant. Applications may be submitted through the Cedars Sinai Career Page here - https://careers.cshs.org/job/california/brca-center-director/252/94786561440
For questions or additional information or to provide recommendations, please contact: Leah Popescu, Executive Director Faculty & Provider Recruitment at [email protected]
Our compensation philosophy
We offer competitive total compensation that includes pay, benefits, and other incentive programs for our employees. The total pay range shown above takes into account the wide range of factors that are considered in making compensation decisions including knowledge/skills; relevant experience and training; education/certifications/licensure; and other business and organizational factors. This total pay range includes any incentive payments that may be applicable to this role. We also offer a comprehensive faculty benefits package. Pay Range: $ 400,000 – 682,000.
About Cedars-Sinai Cancer Center
Cedars-Sinai Cancer Center is dedicated to advancing cancer research, patient care, and innovation for a highly diverse population. The Center’s mission is to address unmet cancer needs regionally and nationally, translate discoveries into real-world impact, and uphold Cedars-Sinai’s values of excellence, inclusion, and compassionate care. Current priorities include precision medicine, novel therapies, and health equity, with a growing focus on screening, prevention, and survivorship.
The Cancer Center is expanding its innovation ecosystem through initiatives including the Computational Biomedicine and Data Sciences Initiative, the Board of Governors Innovation Center (BOGIC), and the Molecular Twin Initiative. Cedars-Sinai also supports an integrated care model that emphasizes patient-centered, high-value care, access to clinical trials, and seamless patient navigation.
The Center treats more patients than any other regional center, covering more than 60 cancer types through a network of owned and affiliated locations. Its academic enterprise spans four missions: clinical service and indigent care, research, education, and technology applications. Patients benefit from 200+ clinical trials, and the research community is supported by 182 members across basic discovery, clinical/translational research, and cancer prevention/control.
Education and training are supported through the Cancer Research Training and Education Coordination Office (CRTEC), which helps develop future cancer researchers and addresses disparities across professional and patient communities.
A major driver of growth is the Department of Computational Biomedicine (launched in 2021), which has expanded infrastructure and talent in AI, machine learning, bioinformatics, biostatistics, and data science—and now includes the Center for Artificial Intelligence Research and Education (CAIRE). This effort supports data-driven, precision oncology advances such as the Molecular Twin Precision Oncology Platform.
Cancer Center by the Numbers
- FY24 Inpatient Volume: 9,213
- FY24 Outpatient Volume: 302,843
- FY23 Publications: 253
- Core Members: 126
- Total Members: 182
- FY23 Grant Funding: $35,618,754
